Standard
What is on the horizon for type 2 diabetes pharmacotherapy? - An overview of the antidiabetic drug development pipeline. / Johansson, Karl Sebastian; Sonne, David; Knop, Filip Krag; Christensen, Mikkel Bring.
In:
Expert Opinion on Drug Discovery, Vol. 15, No. 11, 2020, p. 1253-1265.
Research output: Contribution to journal › Review › Research › peer-review
Harvard
Johansson, KS, Sonne, D
, Knop, FK & Christensen, MB 2020, '
What is on the horizon for type 2 diabetes pharmacotherapy? - An overview of the antidiabetic drug development pipeline',
Expert Opinion on Drug Discovery, vol. 15, no. 11, pp. 1253-1265.
https://doi.org/10.1080/17460441.2020.1791078APA
Johansson, K. S., Sonne, D.
, Knop, F. K., & Christensen, M. B. (2020).
What is on the horizon for type 2 diabetes pharmacotherapy? - An overview of the antidiabetic drug development pipeline.
Expert Opinion on Drug Discovery,
15(11), 1253-1265.
https://doi.org/10.1080/17460441.2020.1791078Vancouver
Johansson KS, Sonne D
, Knop FK, Christensen MB.
What is on the horizon for type 2 diabetes pharmacotherapy? - An overview of the antidiabetic drug development pipeline.
Expert Opinion on Drug Discovery. 2020;15(11):1253-1265.
https://doi.org/10.1080/17460441.2020.1791078Author
Johansson, Karl Sebastian ; Sonne, David ; Knop, Filip Krag ; Christensen, Mikkel Bring. / What is on the horizon for type 2 diabetes pharmacotherapy? - An overview of the antidiabetic drug development pipeline. In: Expert Opinion on Drug Discovery. 2020 ; Vol. 15, No. 11. pp. 1253-1265.
Bibtex
@article{1dfb4b60f3af4a89bd877c6a9de52c59,
title = "What is on the horizon for type 2 diabetes pharmacotherapy? - An overview of the antidiabetic drug development pipeline",
keywords = "Antidiabetic, type 2 diabetes (T2D), diabetes treatment, pipeline, development",
author = "Johansson, {Karl Sebastian} and David Sonne and Knop, {Filip Krag} and Christensen, {Mikkel Bring}",
year = "2020",
doi = "10.1080/17460441.2020.1791078",
language = "English",
volume = "15",
pages = "1253--1265",
journal = "Expert Opinion on Drug Discovery",
issn = "1746-0441",
publisher = "Taylor & Francis",
number = "11",
}
RIS
TY - JOUR
T1 - What is on the horizon for type 2 diabetes pharmacotherapy? - An overview of the antidiabetic drug development pipeline
AU - Johansson, Karl Sebastian
AU - Sonne, David
AU - Knop, Filip Krag
AU - Christensen, Mikkel Bring
PY - 2020
Y1 - 2020
KW - Antidiabetic
KW - type 2 diabetes (T2D)
KW - diabetes treatment
KW - pipeline
KW - development
U2 - 10.1080/17460441.2020.1791078
DO - 10.1080/17460441.2020.1791078
M3 - Review
C2 - 32646248
VL - 15
SP - 1253
EP - 1265
JO - Expert Opinion on Drug Discovery
JF - Expert Opinion on Drug Discovery
SN - 1746-0441
IS - 11
ER -
